Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,100
Closed -$603K 4647
2025
Q4
$603K Sell
8,100
-12,100
-60% -$884K ﹤0.01% 2836
2025
Q3
$1.36M Buy
20,200
+8,800
+77% +$584K 0.01% 1855
2025
Q2
$743K Buy
11,400
+8,700
+322% +$521K ﹤0.01% 2295
2025
Q1
$167K Sell
2,700
-10,400
-79% -$689K ﹤0.01% 3394
2024
Q4
$944K Buy
13,100
+4,400
+51% +$344K ﹤0.01% 2435
2024
Q3
$709K Sell
8,700
-7,900
-48% -$632K ﹤0.01% 2975
2024
Q2
$1.23M Sell
16,600
-5,700
-26% -$427K ﹤0.01% 2618
2024
Q1
$1.74M Buy
22,300
+21,600
+3,086% +$1.61M ﹤0.01% 2096
2023
Q4
$50K Sell
700
-4,100
-85% -$285K ﹤0.01% 4302
2023
Q3
$333K Buy
4,800
+600
+14% +$45.3K ﹤0.01% 3146
2023
Q2
$340K Buy
4,200
+500
+14% +$40.9K ﹤0.01% 2703
2023
Q1
$299K Buy
+3,700
New +$298K ﹤0.01% 2129

Other funds holding HOLX

Walleye Capital's HOLX Position: Q1 2026 in Review

Walleye Capital sold out of Hologic (HOLX) in Q1 2026, closing a stake of 20,002 shares — an estimated $1.49M sold.

Walleye Capital first reported a position in HOLX in Q4 2019 and held it in 14 quarters. The position peaked at $2.57M in Q4 2024. 703 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Walleye Capital reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 20,002 Hologic shares in Q1 2026, an estimated $1.49M.
  • Walleye Capital first reported a position in Hologic in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Hologic position peaked at $2.57M in Q4 2024.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.